AMSTERDAM, Jan. 30, 2019 /PRNewswire/ -- Core Laboratories
N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations
resulted in fourth quarter 2018 revenue of $173,200,000, up 2% year-over-year, with operating
income of $18,000,000 and earnings per diluted share ("EPS") of $0.19, all in accordance with U.S. generally accepted accounting principles ("GAAP"); operating income,
ex-items, a non-GAAP financial measure, was $28,400,000 and EPS, ex-items, was $0.48. During the fourth quarter of 2018, the Company recorded approximately $10,000,000 of non-cash stock compensation expense, in accordance with FASB ASC Topic 718, "Compensation -
Stock Compensation", associated with certain executives reaching their eligible retirement age. These long-term incentive awards
continue to be subject to their future vesting schedules and company financial performance metrics. Reconciliations of
non-GAAP financial measures are included in the attached financial tables.
Core's Board of Supervisory Directors ("Board") and the Company's Executive Management continue to focus on strategies that
maximize return on invested capital ("ROIC") and free cash flow ("FCF"), a non-GAAP financial measure defined as cash from
operations less capital expenditures, while exercising capital discipline, factors that have high correlation with maximizing
total shareholder return. Core's asset-light business model promotes capital efficiency, designed to produce more predictable,
superior long-term, and sustainable ROIC. Bloomberg's calculations using the latest comparable data available indicate that
Core's ROIC of 24.5% is the highest for all major companies in its oilfield service Comp Group.
Segment Highlights
Reservoir Description
Reservoir Description is heavily exposed to international and offshore activity levels. Over 80% of its revenue is
sourced outside the U.S., where core, reservoir fluid and derived product samples originate from international projects. The
continued slow recovery of international and deepwater field development activity impacted revenue opportunities for the
Company's Reservoir Description segment during the fourth quarter of 2018. Revenue in the fourth quarter was $106,600,000, a two-year high, with operating income on a GAAP basis of $10,400,000. Operating income, ex-items, was $16,900,000, yielding operating
margins, ex-items, of 16%, up slightly when compared to operating margins posted in the third quarter of 2018 and comparable to
operating margins posted in the fourth quarter of 2017.
International industry activity has been effectively flat year-over-year through the fourth quarter of 2018. In addition
to the muted activity in international markets, the Gulf of Mexico ("GOM") and other deepwater
provinces have also been slow to recover. However, Core is encouraged by the continued increase in client conversations regarding
new international and offshore projects for 2019 and beyond. Final Investment Decisions ("FIDs") related to upstream
projects continue to be approved, with approximately 25 in 2017 and 30 in 2018. However, the pace at which these projects
are progressing after approval has been slower than in previous recovery cycles.
The analytical program for Core Lab's Unconventional Enhanced Oil Recovery ("EOR") Joint Industry Project ("JIP") in the
Permian Basin, announced in the third quarter of 2018, has begun. This study is focused on incremental oil recovery from
cyclic engineered-gas injection in the Wolfcamp Formation in both the Midland and Delaware Basins. The Permian Basin EOR
JIP follows two highly successful Core Lab JIPs in the Midland and Delaware Basins, which were conducted for over 75
operators. Those earlier studies focused on the geological and petrophysical properties of target reservoir horizons, and
therefore provide a critical foundation for the recently initiated Unconventional EOR JIP in the Wolfcamp Formation. Due to
steep decline curves and low recovery factors in these nano-darcy rocks, there is a necessity to assess the effectiveness of
enhanced oil recovery techniques. The technological and analytical methodologies used in this new Unconventional EOR JIP
are the summation of years of proprietary experience in unconventional EOR testing, and in providing analytical data sets to
operators to help them optimize their reservoirs.
Production Enhancement
Production Enhancement operations, largely focused on complex completions in unconventional tight-oil reservoirs in the U.S.
and conventional offshore development projects, posted fourth quarter 2018 revenue of $66,700,000,
up 2% year-over-year. GAAP operating income was $7,700,000, while operating income, ex-items, was
$11,600,000 and operating margins, ex-items, were over 17%. Production Enhancement
performance was affected by a slow-down in U.S. onshore completion activity in the fourth quarter of 2018.
For the past five years, Core has been working closely with a major E&P company to help optimize their Bakken and Three
Forks completions in terms of production and completion efficiency. Early on, this operator tested sliding sleeve
completion designs, but continued to compare their sliding sleeve completions with plug & perf completions. By utilizing
Core's SpectraStimTM tracing and SpectraScan® well diagnostic services, the operator was able to
demonstrate more consistent formation entry and improved efficiencies using a higher number of perf clusters as compared to
sliding sleeve methods. Most recently, Core's well diagnostics have demonstrated that the operator could also optimize
their frac stage lengths without sacrificing cluster treatment efficiencies and stimulated reservoir volumes. These data sets
also help to clarify well performance metrics, and lower completion costs, by allowing the operator to reduce the number of frac
stages by approximately 25% to 40% when using the plug & perf technique compared to sliding sleeve. In a recent statement,
the operator reported that this process of moving away from sliding sleeves and to plug & perf completions in the Bakken has
helped reduce costs by approximately 60%, while generating a 15 to 20% improvement in well production performance over the first
180 days.
The integration of Guardian Global Technologies into Core's Production Enhancement business segment is well underway. The
Production Enhancement team is sharply focused on proprietary downhole energetic solutions designed to systemize, simplify,
automate, and de-risk the deployment of the perforating system. As part of the integration, Core began the introduction of
the new preassembled GoGunTM Adaptive Perforating System in the fourth quarter of 2018. This system combines
Guardian's best-in-class patented addressable Select Fire Switch (SFS)TM technology with Core's proprietary energetics
into a prewired, integrated perforating system. The GoGunTM is an "open architecture" system that gives the
operator enhanced flexibility in completion designs for wellsite efficiency and reservoir performance.
With the acquisition of Guardian Global Technologies, Core has introduced the Guardian Ballistics Delivery System
(BDS)TM, an advanced wellbore communication system driven by client demand. When combined with Core's
differentiated perforating systems and energetics, Core now provides the industry with the only total perforating solution.
The BDS, combined with Core's variety of technologically advanced energetic products, will assist Core's clients in optimizing
the downhole tool-string for each perforating operation. As a result, clients will be able to better manage the outcome of
their investment with faster and safer operations, while also reducing the risk of unplanned downhole events. The BDS
communication protocols automatically detect which products are present in the tool-string and can be configured for the client's
desired downhole communication requirements.
Utilizing the advanced BDS, the new preassembled GoGunTM and Core Lab's proprietary energetics, such as
HERO®PerFRAC, allows the operator to optimize wellsite efficiency, perforating accuracy and reliability. Core's
patented and proprietary energetics and perforating systems now lead the market offerings for ultra-high-end completions in
unconventional reservoirs. Together with Guardian Global Technologies, Core now provides technology across the entire
completion string, from the cable head to the bridge plug, in a way not currently offered by other oilfield service
providers. Core Lab expects Guardian's addressable downhole capabilities, combined with Core's proprietary perforating
systems and energetics, to lead to the introduction of differentiated and market-disruptive perforating technologies in 2019 and
beyond, expanding its participation in the multi-billion dollar perforating market.
Free Cash Flow, Dividends and Share Repurchases
During the fourth quarter of 2018, Core continued to generate FCF, with cash from operations of $37,900,000 and capital expenditures of $5,700,000, yielding FCF of $32,200,000, representing more than 152% of income from continuing operations, ex-items. This free cash was
returned to Core's shareholders via the Company's regular quarterly dividend and share repurchases, with the remainder used to
reduce debt. Core continues its commitment to investment for growth and generating FCF that is returned to shareholders via
the Company's regular quarterly dividend and opportunistic share repurchases. During the quarter, Core repurchased 42,991
shares at an average share price of $62.21.
For the fiscal year 2018, capex spending was held below $21,800,000, commensurate with Core's
longstanding tradition of aligning capital discipline with market conditions. For the past three years, Core's capex
program has totaled approximately $52,000,000, well below historical levels and significantly below
the Company's total depreciation and amortization of approximately $75,000,000 over the same
period. Core's strict capital discipline and asset-light business model continue to be demonstrated as the capital
investments over this time period are less than 3% of revenue.
On 9 October 2018, the Board announced a quarterly cash dividend of $0.55 per share of common stock, which was paid on 20 November 2018 to
shareholders of record on 19 October 2018. Dutch withholding tax was deducted from the dividend at
a rate of 15%.
On 15 January 2019, the Board announced a quarterly cash dividend of $0.55 per share of common stock, payable in the first quarter of 2019. The quarterly cash dividend will be
payable on 15 February 2019 to shareholders of record on 25 January
2019. Dutch withholding tax will be deducted from the dividend at a rate of 15%.
Return On Invested Capital
Core Lab's ROIC of 24.5% is the highest of the peer group as compiled and reported by Bloomberg. The Company's Board has
established an internal performance metric of achieving a leading relative ROIC performance compared with the oilfield service
companies listed as Core's Comp Group by Bloomberg. The Company and its Board believe that ROIC is a leading long-term
performance metric used by shareholders to determine the relative investment value of publicly traded companies. Further, the
Company and its Board believe that shareholders will benefit if Core consistently performs at high levels of ROIC relative to its
Comp Group. For the fiscal year 2018, Core's total shareholder return outpaced the Philadelphia Oilfield Services Index
("OSX") as it has for 13 of the past 16 years.
According to the latest Comp Group financial information from Bloomberg, Core's ROIC is the highest of any comparably-sized
oilfield service company (greater than $2 billion market capitalization). Comp Group companies
listed by Bloomberg include Halliburton, Schlumberger, National Oilwell Varco, RPC, TGS Nopec Geophysical, and John Wood Group,
among others. Core Lab is one of only three of the 15 companies listed in the Comp Group posting ROIC that exceeded their
Weighted Average Cost of Capital.
First Quarter 2019 Revenue and EPS Guidance
During the fourth quarter 2018, the worldwide crude-oil market added supply, likely in anticipation of the Iran sanctions. Consequently, during November and December, the per-barrel price of crude oil fell by
more than 40% from the year's peak in October 2018. However, global crude-oil inventories exited 2018 at approximately 38
days of consumption, consistent with a multi-year trend of declining global crude-oil inventories related to demand. The
International Energy Agency's most recent estimated worldwide demand projections remain strong with 1,400,000 additional barrels
of oil per day anticipated to be needed in 2019.
After five years of muted investment in international, offshore and deepwater projects, oil companies announced more than 30
upstream FIDs in 2018, an increase of more than 20% from 2017. The renewed investment at a global level is critical in
order to meet future supply needs. Recognition of the need for investment is evidenced by the FIDs announced over the last
two years and Wood McKenzie's estimation of another 30 upstream projects for 2019. However, Core Lab anticipates a slowing
in further project announcements until confidence in the balance of global crude-oil markets is restored. Core believes there
will be a positive correction to the temporary oversupply of crude oil by the end of the first quarter 2019, which should
encourage additional FID approvals for projects announced in 2018.
As customary, Core expects typical sequential seasonal industry patterns will cause the first quarter of 2019 to be down, and
international field development spending will be funded largely from operating budgets. International recovery on a more
broad-based scope is expected to improve as 2019 unfolds. The Company believes that 2019 international growth is expected
to reach mid to high single-digit levels. Reservoir Description continues to discuss international projects with clients,
which are in alignment with FIDs previously announced. The revenue opportunity for Reservoir Description occurs once the well has
been drilled and core and fluid samples are taken and analyzed. Activity levels and revenue opportunities from these FIDs
and the emerging international recovery are expected to have a positive impact on financial performance in 2019.
The average first quarter 2019 U.S. rig count is projected to be flat to modestly down sequentially, with U.S. completion
activity to remain at similar levels exiting 2018, until transitory industry take-away constraints are resolved in the Permian
Basin of West Texas. The drilled-but-uncompleted well inventory should provide Core Lab with future revenue
opportunities. When operator completion activity improves, Production Enhancement's products and services are uniquely
positioned to respond as diagnostic services are mobile and the established distribution network can quickly provide completion
products to all basins throughout the U.S.
Therefore, Core expects consolidated first quarter 2019 revenue of approximately $164,000,000 to
$168,000,000 and operating income of approximately $26,000,000 to
$27,000,000, yielding operating margins of 16%. EPS for the first quarter of 2019 is expected to be
approximately $0.42 to $0.45. The Company's first quarter 2019
guidance is based on projections for the underlying operations, excludes gains and losses in foreign exchange and assumes an
effective tax rate of 15%. The projected effective tax rate considers the Company's on-going evaluation of corporate
restructuring, which is expected to yield a lower tax rate than previously forecasted. Core's first quarter 2019 guidance
compares favorably to the other major oilfield service companies that have reported fourth quarter results, and have projected
EPS declines from fourth quarter 2018 to first quarter 2019 ranging from approximately 15% to over 30%.
Earnings Call Scheduled
The Company has scheduled a conference call to discuss Core's fourth quarter 2018 earnings announcement. The call will begin
at 7:30 a.m. CST / 2:30 p.m. CET on Thursday, 31 January 2019. To listen to the call, please go to Core's website at www.corelab.com.
Core Laboratories N.V. (www.corelab.com) is a leading provider of
proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum
reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major
oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements
regarding the future revenue, profitability, business strategies and developments of the Company made in reliance upon the safe
harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including
risks and uncertainties related to the oil and natural gas industry, business conditions, international markets, international
political climates and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or
furnished to the Securities and Exchange Commission. These important factors could cause the Company's actual results to
differ materially from those described in these forward-looking statements. Such statements are based on current expectations of
the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company.
Because the information herein is based solely on data currently available, and because it is subject to change as a result of
changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as
assurance regarding the Company's future performance. The Company undertakes no obligation to publicly update or revise any
forward looking statement to reflect events or circumstances that may arise after the date of this press release, except as
required by law.
Visit the Company's website at www.corelab.com. Connect with Core Lab on
Facebook, LinkedIn and YouTube.
CORE LABORATORIES N.V. & SUBSIDIARIES
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
|
(amounts in thousands, except per share data)
|
(Unaudited)
|
|
|
|
Three Months Ended
|
|
% Variance
|
|
|
Dec 31, 2018
|
|
Sep 30, 2018
|
|
Dec 31, 2017
|
|
vs Q3-18
|
|
vs Q4-17
|
REVENUE
|
$
|
173,207
|
|
|
$
|
182,146
|
|
|
$
|
170,111
|
|
|
(4.9)%
|
|
1.8%
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES:
|
|
|
|
|
|
|
|
|
|
|
Costs of services and sales
|
125,694
|
|
|
128,179
|
|
|
119,942
|
|
|
(1.9)%
|
|
4.8%
|
|
General and administrative expenses
|
24,721
|
|
|
13,278
|
|
|
11,994
|
|
|
86.2%
|
|
106.1%
|
|
Depreciation and amortization
|
5,721
|
|
|
5,680
|
|
|
6,038
|
|
|
0.7%
|
|
(5.3)%
|
|
Other (income) expense, net
|
(907)
|
|
|
130
|
|
|
(268)
|
|
|
NM
|
|
NM
|
|
Total operating expenses
|
155,229
|
|
|
147,267
|
|
|
137,706
|
|
|
5.4%
|
|
12.7%
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING INCOME
|
17,978
|
|
|
34,879
|
|
|
32,405
|
|
|
(48.5)%
|
|
(44.5)%
|
Interest expense
|
3,634
|
|
|
3,278
|
|
|
2,717
|
|
|
10.9%
|
|
33.8%
|
Income from continuing operations before income tax expense
|
14,344
|
|
|
31,601
|
|
|
29,688
|
|
|
(54.6)%
|
|
(51.7)%
|
Income tax expense
|
5,750
|
|
|
9,404
|
|
|
8,016
|
|
|
(38.9)%
|
|
(28.3)%
|
Income from continuing operations
|
8,594
|
|
|
22,197
|
|
|
21,672
|
|
|
(61.3)%
|
|
(60.3)%
|
Income (loss) from discontinued operations
|
408
|
|
|
208
|
|
|
(20)
|
|
|
NM
|
|
NM
|
Net income
|
9,002
|
|
|
22,405
|
|
|
21,652
|
|
|
(59.8)%
|
|
(58.4)%
|
Net income (loss) attributable to non-controlling interest
|
167
|
|
|
(7)
|
|
|
(39)
|
|
|
NM
|
|
NM
|
Net income attributable to Core Laboratories N.V.
|
$
|
8,835
|
|
|
$
|
22,412
|
|
|
$
|
21,691
|
|
|
(60.6)%
|
|
(59.3)%
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Earnings Per Share from Continuing Operations
|
$
|
0.19
|
|
|
$
|
0.50
|
|
|
$
|
0.49
|
|
|
(62.0)%
|
|
(61.2)%
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Earnings Per Share attributable to Core Laboratories
N.V.
|
$
|
0.20
|
|
|
$
|
0.50
|
|
|
$
|
0.49
|
|
|
(60.0)%
|
|
(59.2)%
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Avg Diluted Common Shares Outstanding
|
44,401
|
|
|
44,591
|
|
|
44,276
|
|
|
(0.4)%
|
|
0.3%
|
|
|
|
|
|
|
|
|
|
|
|
Effective Tax Rate
|
40
|
%
|
|
30
|
%
|
|
27
|
%
|
|
33.3%
|
|
48.1%
|
|
|
|
|
|
|
|
|
|
|
|
SEGMENT INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
Reservoir Description
|
$
|
106,557
|
|
|
$
|
103,609
|
|
|
$
|
104,570
|
|
|
2.8%
|
|
1.9%
|
Production Enhancement
|
66,650
|
|
|
78,537
|
|
|
65,541
|
|
|
(15.1)%
|
|
1.7%
|
|
Total
|
$
|
173,207
|
|
|
$
|
182,146
|
|
|
$
|
170,111
|
|
|
(4.9)%
|
|
1.8%
|
|
|
|
|
|
|
|
|
|
|
|
Operating income:
|
|
|
|
|
|
|
|
|
|
Reservoir Description
|
$
|
10,374
|
|
|
$
|
14,956
|
|
|
$
|
17,269
|
|
|
(30.6)%
|
|
(39.9)%
|
Production Enhancement
|
7,682
|
|
|
19,243
|
|
|
14,085
|
|
|
(60.1)%
|
|
(45.5)%
|
Corporate and other
|
(78)
|
|
|
680
|
|
|
1,051
|
|
|
NM
|
|
NM
|
|
Total
|
$
|
17,978
|
|
|
$
|
34,879
|
|
|
$
|
32,405
|
|
|
(48.5)%
|
|
(44.5)%
|
|
|
|
|
|
|
|
|
|
|
|
CORE LABORATORIES N.V. & SUBSIDIARIES
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
|
(amounts in thousands, except per share data)
|
(Unaudited)
|
|
|
|
Twelve Months ended
|
|
% Variance
|
|
|
Dec 31, 2018
|
|
Dec 31, 2017
|
|
vs 2017
|
|
|
|
|
|
|
|
REVENUE
|
$
|
700,846
|
|
|
$
|
647,819
|
|
|
8.2%
|
|
|
|
|
|
|
|
OPERATING EXPENSES:
|
|
|
|
|
|
|
Costs of services and sales
|
496,964
|
|
|
464,958
|
|
|
6.9%
|
|
General and administrative expenses
|
62,910
|
|
|
47,737
|
|
|
31.8%
|
|
Depreciation and amortization
|
23,087
|
|
|
24,524
|
|
|
(5.9)%
|
|
Other (income) expense, net
|
(737)
|
|
|
632
|
|
|
NM
|
|
Total operating expenses
|
582,224
|
|
|
537,851
|
|
|
8.3%
|
|
|
|
|
|
|
|
OPERATING INCOME
|
118,622
|
|
|
109,968
|
|
|
7.9%
|
Interest expense
|
13,328
|
|
|
10,734
|
|
|
24.2%
|
|
|
|
|
|
|
|
Income from continuing operations before income tax expense
|
105,294
|
|
|
99,234
|
|
|
6.1%
|
Income tax expense
|
25,447
|
|
|
18,249
|
|
|
39.4%
|
Income from continuing operations
|
79,847
|
|
|
80,985
|
|
|
(1.4)%
|
Income (loss) from discontinued operations
|
(58)
|
|
|
2,111
|
|
|
NM
|
Net income
|
79,789
|
|
|
83,096
|
|
|
(4.0)%
|
Net income (loss) attributable to non-controlling interest
|
263
|
|
|
(29)
|
|
|
NM
|
Net income attributable to Core Laboratories N.V.
|
$
|
79,526
|
|
|
$
|
83,125
|
|
|
(4.3)%
|
|
|
|
|
|
|
|
Diluted Earnings Per Share from Continuing Operations
|
$
|
1.80
|
|
|
$
|
1.83
|
|
|
(1.6)%
|
|
|
|
|
|
|
|
Diluted Earnings Per Share attributable to Core Laboratories N.V.
|
$
|
1.79
|
|
|
$
|
1.88
|
|
|
(4.8)%
|
|
|
|
|
|
|
|
Weighted Avg Diluted Common Shares Outstanding
|
44,474
|
|
|
44,264
|
|
|
0.5%
|
|
|
|
|
|
|
|
Effective Tax Rate
|
24
|
%
|
|
18
|
%
|
|
33.3%
|
|
|
|
|
|
|
|
SEGMENT INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
Reservoir Description
|
$
|
413,082
|
|
|
$
|
415,220
|
|
|
(0.5)%
|
Production Enhancement
|
287,764
|
|
|
232,599
|
|
|
23.7%
|
|
Total
|
$
|
700,846
|
|
|
$
|
647,819
|
|
|
8.2%
|
|
|
|
|
|
|
|
Operating income:
|
|
|
|
|
|
Reservoir Description
|
$
|
54,847
|
|
|
$
|
66,500
|
|
|
(17.5)%
|
Production Enhancement
|
63,039
|
|
|
43,987
|
|
|
43.3%
|
Corporate and other
|
736
|
|
|
(519)
|
|
|
NM
|
|
Total
|
$
|
118,622
|
|
|
$
|
109,968
|
|
|
7.9%
|
CORE LABORATORIES N.V. & SUBSIDIARIES
|
CONDENSED CONSOLIDATED BALANCE SHEET
|
(amounts in thousands)
|
|
|
|
|
|
|
|
|
|
% Variance
|
ASSETS:
|
Dec 31, 2018
|
|
Sep 30, 2018
|
|
Dec 31, 2017
|
|
vs Q3-18
|
|
vs Q4-17
|
|
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents
|
$
|
13,116
|
|
|
$
|
14,100
|
|
|
$
|
14,400
|
|
|
(7.0)%
|
|
(8.9)%
|
Accounts Receivable, net
|
129,157
|
|
|
143,325
|
|
|
133,097
|
|
|
(9.9)%
|
|
(3.0)%
|
Inventory
|
45,664
|
|
|
47,215
|
|
|
33,317
|
|
|
(3.3)%
|
|
37.1%
|
Other Current Assets
|
43,040
|
|
|
34,485
|
|
|
26,613
|
|
|
24.8%
|
|
61.7%
|
|
Total Current Assets
|
230,977
|
|
|
239,125
|
|
|
207,427
|
|
|
(3.4)%
|
|
11.4%
|
|
|
|
|
|
|
|
|
|
|
|
Property, Plant and Equipment, net
|
122,917
|
|
|
121,945
|
|
|
123,098
|
|
|
0.8%
|
|
(0.1)%
|
Intangibles, Goodwill and Other Long Term Assets, net
|
294,933
|
|
|
305,527
|
|
|
254,287
|
|
|
(3.5)%
|
|
16.0%
|
|
Total Assets
|
$
|
648,827
|
|
|
$
|
666,597
|
|
|
$
|
584,812
|
|
|
(2.7)%
|
|
10.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts Payable
|
$
|
41,155
|
|
|
$
|
41,012
|
|
|
$
|
41,697
|
|
|
0.3%
|
|
(1.3)%
|
Other Current Liabilities
|
61,392
|
|
|
62,497
|
|
|
58,879
|
|
|
(1.8)%
|
|
4.3%
|
|
Total Current Liabilities
|
102,547
|
|
|
103,509
|
|
|
100,576
|
|
|
(0.9)%
|
|
2.0%
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Debt & Lease Obligations
|
289,770
|
|
|
295,745
|
|
|
226,989
|
|
|
(2.0)%
|
|
27.7%
|
Other Long-Term Liabilities
|
95,610
|
|
|
105,931
|
|
|
108,515
|
|
|
(9.7)%
|
|
(11.9)%
|
|
|
|
|
|
|
|
|
|
|
Total Equity
|
160,900
|
|
|
161,412
|
|
|
148,732
|
|
|
(0.3)%
|
|
8.2%
|
|
Total Liabilities and Equity
|
$
|
648,827
|
|
|
$
|
666,597
|
|
|
$
|
584,812
|
|
|
(2.7)%
|
|
10.9%
|
CORE LABORATORIES N.V. & SUBSIDIARIES
|
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW
|
(amounts in thousands)
|
(Unaudited)
|
|
|
|
|
Three Months Ended
|
|
|
|
Dec 31, 2018
|
|
Sep 30, 2018
|
|
Dec 31, 2017
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
Net Income from continuing operations
|
$
|
8,594
|
|
|
$
|
22,197
|
|
|
$
|
21,672
|
|
|
Income (loss) from discontinued operations
|
408
|
|
|
208
|
|
|
(20)
|
|
|
Net Income
|
9,002
|
|
|
22,405
|
|
|
21,652
|
|
|
Adjustments to reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
|
|
Stock-based compensation
|
15,661
|
|
|
6,141
|
|
|
5,619
|
|
|
Depreciation and amortization
|
5,721
|
|
|
5,680
|
|
|
6,038
|
|
|
Accounts Receivable
|
14,237
|
|
|
(6,547)
|
|
|
(3,077)
|
|
|
Inventory
|
1,718
|
|
|
(5,008)
|
|
|
1,242
|
|
|
Accounts Payable
|
819
|
|
|
(6,011)
|
|
|
6,414
|
|
|
Other adjustments to net income
|
(9,257)
|
|
|
7,183
|
|
|
8,029
|
|
|
|
Net cash provided by operating activities
|
$
|
37,901
|
|
|
$
|
23,843
|
|
|
$
|
45,917
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
Capital expenditures
|
$
|
(5,678)
|
|
|
$
|
(4,148)
|
|
|
$
|
(4,511)
|
|
|
Acquisitions, net of cash acquired
|
—
|
|
|
(47,314)
|
|
|
—
|
|
|
Other investing activities
|
(96)
|
|
|
(89)
|
|
|
(792)
|
|
|
|
Net cash used in investing activities
|
$
|
(5,774)
|
|
|
$
|
(51,551)
|
|
|
$
|
(5,303)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
Repayment of debt borrowings
|
$
|
(34,000)
|
|
|
$
|
(23,000)
|
|
|
$
|
(41,000)
|
|
|
Proceeds from debt borrowings
|
28,000
|
|
|
77,000
|
|
|
34,000
|
|
|
Dividends paid
|
(24,322)
|
|
|
(24,294)
|
|
|
(24,282)
|
|
|
Repurchase of treasury shares
|
(2,674)
|
|
|
(817)
|
|
|
(8,712)
|
|
|
Other financing activities
|
(115)
|
|
|
(102)
|
|
|
—
|
|
|
|
Net cash used in financing activities
|
$
|
(33,111)
|
|
|
$
|
28,787
|
|
|
$
|
(39,994)
|
|
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS
|
(984)
|
|
|
1,079
|
|
|
620
|
|
CASH AND CASH EQUIVALENTS, beginning of period
|
14,100
|
|
|
13,021
|
|
|
13,780
|
|
CASH AND CASH EQUIVALENTS, end of period
|
$
|
13,116
|
|
|
$
|
14,100
|
|
|
$
|
14,400
|
|
CORE LABORATORIES N.V. & SUBSIDIARIES
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
|
(amounts in thousands)
|
(Unaudited)
|
|
|
|
|
Twelve Months ended
|
|
|
|
Dec 31, 2018
|
|
Dec 31, 2017
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
Net Income from continuing operations
|
$
|
79,847
|
|
|
$
|
80,985
|
|
|
Income (loss) from discontinued operations
|
(58)
|
|
|
2,111
|
|
|
Net Income
|
$
|
79,789
|
|
|
$
|
83,096
|
|
|
Adjustments to reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
Stock-based compensation
|
34,194
|
|
|
22,942
|
|
|
Depreciation and amortization
|
23,087
|
|
|
24,524
|
|
|
Accounts Receivable
|
2,265
|
|
|
(18,565)
|
|
|
Inventory
|
(10,403)
|
|
|
446
|
|
|
Accounts Payable
|
(1,752)
|
|
|
8,721
|
|
|
Other adjustments to net income
|
(15,353)
|
|
|
3,107
|
|
|
|
Net cash provided by operating activities
|
$
|
111,827
|
|
|
$
|
124,271
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
Capital expenditures
|
$
|
(21,741)
|
|
|
$
|
(18,775)
|
|
|
Business acquisitions
|
(47,314)
|
|
|
—
|
|
|
Other investing activities
|
(1,584)
|
|
|
(1,782)
|
|
|
|
Net cash used in investing activities
|
$
|
(70,639)
|
|
|
$
|
(20,557)
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
Repayment of debt borrowings
|
$
|
(114,000)
|
|
|
$
|
(130,000)
|
|
|
Proceeds from debt borrowings
|
178,000
|
|
|
140,000
|
|
|
Dividends paid
|
(97,251)
|
|
|
(97,143)
|
|
|
Repurchase of treasury shares
|
(7,451)
|
|
|
(16,909)
|
|
|
Other financing activities
|
(1,770)
|
|
|
(26)
|
|
|
|
Net cash used in financing activities
|
$
|
(42,472)
|
|
|
$
|
(104,078)
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS
|
(1,284)
|
|
|
(364)
|
|
CASH AND CASH EQUIVALENTS, beginning of period
|
14,400
|
|
|
14,764
|
|
CASH AND CASH EQUIVALENTS, end of period
|
$
|
13,116
|
|
|
$
|
14,400
|
|
Non-GAAP Information
Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively
the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded
Items. For this reason, we use certain non-GAAP measures that exclude these Items; and we feel that this presentation
provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be
considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully
discussed in the Company's financial statement and filings with the Securities and Exchange Commission.
Reconciliation of Operating Income, Income from Continuing Operations
and Earnings Per Diluted Share from Continuing Operations
|
(amounts in thousands, except per share data)
|
(Unaudited)
|
|
|
|
Operating Income from Continuing Operations
|
|
Three Months Ended
|
|
Dec 31, 2018
|
|
Sep 30, 2018
|
|
Dec 31, 2017
|
GAAP reported
|
$
|
17,978
|
|
|
$
|
34,879
|
|
|
$
|
32,405
|
|
Foreign exchange losses
|
457
|
|
|
1,135
|
|
|
350
|
|
Stock compensation costs (1)
|
10,012
|
|
|
—
|
|
|
—
|
|
Acquisition costs
|
—
|
|
|
656
|
|
|
—
|
|
Excluding specific items
|
$
|
28,447
|
|
|
$
|
36,670
|
|
|
$
|
32,755
|
|
|
(1) Stock compensation expense recognized pursuant to FASB ASC 718 "Stock
Compensation" associated with executives reaching eligible retirement age.
|
|
|
Income from Continuing Operations
|
|
Three Months Ended
|
|
Dec 31, 2018
|
|
Sep 30, 2018
|
|
Dec 31, 2017
|
GAAP reported
|
$
|
8,594
|
|
|
$
|
22,197
|
|
|
$
|
21,672
|
|
Foreign exchange losses
|
274
|
|
|
799
|
|
|
255
|
|
Stock compensation costs
|
9,165
|
|
|
—
|
|
|
—
|
|
Acquisition costs
|
—
|
|
|
462
|
|
|
—
|
|
Impact of higher tax rate (1)
|
3,059
|
|
|
4,925
|
|
|
3,604
|
|
Excluding specific items
|
$
|
21,092
|
|
|
$
|
28,383
|
|
|
$
|
25,531
|
|
|
|
|
|
|
|
(1) 2018-Q4 tax rate of 40%; guidance given at 15%. Quarter 4 includes
stock compensation expense which is non deductible in the U.S.
|
2018-Q3 tax rate of 30%; guidance given at 15%. Quarter 3 includes
several items discrete to the quarter along with changes in activity levels in jurisdictions with differing tax
rates.
|
2017-Q4 tax rate of 27%; guidance given at 15%
|
|
|
|
|
Earnings Per Diluted Share from Continuing Operations
|
|
Three Months Ended
|
|
Dec 31, 2018
|
|
Sep 30, 2018
|
|
Dec 31, 2017
|
GAAP reported
|
$
|
0.19
|
|
|
$
|
0.50
|
|
|
$
|
0.49
|
|
Foreign exchange losses
|
0.01
|
|
|
0.02
|
|
|
0.01
|
|
Stock compensation costs
|
0.21
|
|
|
—
|
|
|
—
|
|
Acquisition costs
|
—
|
|
|
0.01
|
|
|
—
|
|
Impact of higher tax rate (1)
|
0.07
|
|
|
0.11
|
|
|
0.08
|
|
Excluding specific items
|
$
|
0.48
|
|
|
$
|
0.64
|
|
|
$
|
0.58
|
|
|
|
|
|
|
|
(1) 2018-Q4 tax rate of 40%; guidance given at 15%. Quarter 4 includes
stock compensation expense which is non deductible in the U.S.
|
2018-Q3 tax rate of 30%; guidance given at 15%. Quarter 3 includes
several items discrete to the quarter along with changes in activity levels in jurisdictions with differing tax
rates.
|
2017-Q4 tax rate of 27%; guidance given at 15%
|
Segment Information
|
(amounts in thousands)
|
(Unaudited)
|
|
|
|
Operating Income from Continuing Operations
|
|
Three Months Ended 31 December 2018
|
|
Reservoir
Description
|
|
Production
Enhancement
|
|
Corporate and
Other
|
|
GAAP reported
|
$
|
10,374
|
|
|
$
|
7,682
|
|
|
$
|
(78)
|
|
|
Foreign exchange losses
|
255
|
|
|
124
|
|
|
78
|
|
|
Stock compensation costs
|
6,266
|
|
|
3,746
|
|
|
—
|
|
|
Excluding specific items
|
$
|
16,895
|
|
|
$
|
11,552
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
Return on Invested Capital
Return on Invested Capital ("ROIC") is based on Bloomberg's calculation on the trailing four quarters from the most recently
reported quarter and the balance sheet of the most recent reported quarter, and is presented based on our belief that this
non-GAAP measure is useful information to investors and management when comparing our profitability and the efficiency with which
we have employed capital over time relative to other companies. ROIC is not a measure of financial performance under GAAP and
should not be considered as an alternative to net income.
ROIC of 24.5% is defined by Bloomberg as Net Operating Profit ("NOP") of $134 million less Cash
Operating Taxes ("COT") of $22 million divided by Total Invested Capital ("TIC") of $457 million, where NOP is defined as GAAP net income before minority interest plus income tax expense plus
Interest expense plus pension expense less pension service cost and COT is defined as income tax expense plus change in net
deferred taxes plus the tax effect on Interest expense and TIC is defined as GAAP stockholder's equity plus net long-term debt
plus allowance for doubtful accounts plus net balance of deferred taxes plus income tax payable.
Free Cash Flow
Core uses the non-GAAP measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is an
important measurement because it represents the cash from operations, in excess of capital expenditures, available to operate the
business and fund non-discretionary obligations. Free cash flow is not a measure of operating performance under GAAP, and should
not be considered in isolation nor construed as an alternative consideration to operating income, net income, earnings per share,
or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash
flow should not be considered a measure of liquidity. Moreover, since free cash flow is not a measure determined in accordance
with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable
to similarly titled measures presented by other companies.
Computation of Free Cash Flow
|
(amounts in thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Twelve Months ended
|
|
|
Dec 31, 2018
|
|
Dec 31, 2018
|
Net cash provided by operating activities
|
|
$
|
37,901
|
|
|
$
|
111,827
|
|
Capital expenditures
|
|
(5,678)
|
|
|
(21,741)
|
|
Free cash flow
|
|
$
|
32,223
|
|
|
$
|
90,086
|
|
View original content to download multimedia:http://www.prnewswire.com/news-releases/core-lab-reports-fourth-quarter-2018-results-from-continuing-operations-300787142.html
SOURCE Core Laboratories N.V.